Ronald Joseph Gurrera, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroleptic Malignant Syndrome | 14 | 2017 | 74 | 3.340 |
Why?
|
| Clozapine | 4 | 2022 | 509 | 1.590 |
Why?
|
| Mental Competency | 6 | 2013 | 179 | 1.160 |
Why?
|
| Antipsychotic Agents | 9 | 2022 | 3081 | 1.100 |
Why?
|
| Pneumonia, Aspiration | 2 | 2018 | 145 | 1.050 |
Why?
|
| Informed Consent | 6 | 2013 | 1010 | 0.830 |
Why?
|
| Hyponatremia | 2 | 2019 | 279 | 0.770 |
Why?
|
| Schizophrenic Psychology | 8 | 2014 | 1649 | 0.680 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2019 | 87 | 0.640 |
Why?
|
| Personality Disorders | 4 | 2014 | 726 | 0.610 |
Why?
|
| Personality | 5 | 2005 | 559 | 0.540 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2017 | 62 | 0.540 |
Why?
|
| Neutropenia | 1 | 2022 | 892 | 0.540 |
Why?
|
| Myocarditis | 2 | 2022 | 802 | 0.480 |
Why?
|
| Schizotypal Personality Disorder | 2 | 2006 | 289 | 0.470 |
Why?
|
| Serotonin Syndrome | 1 | 2013 | 18 | 0.450 |
Why?
|
| Trazodone | 1 | 2013 | 67 | 0.450 |
Why?
|
| Tramadol | 1 | 2013 | 63 | 0.430 |
Why?
|
| Schizophrenia | 12 | 2016 | 6983 | 0.420 |
Why?
|
| Oxycodone | 1 | 2013 | 144 | 0.400 |
Why?
|
| Bupropion | 1 | 2013 | 303 | 0.390 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2017 | 1988 | 0.380 |
Why?
|
| Professional Competence | 1 | 2014 | 430 | 0.360 |
Why?
|
| Neuropsychological Tests | 9 | 2014 | 7140 | 0.360 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2013 | 491 | 0.360 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2005 | 533 | 0.340 |
Why?
|
| Personality Inventory | 8 | 2014 | 1018 | 0.340 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 2057 | 0.330 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2271 | 0.320 |
Why?
|
| Consensus | 2 | 2017 | 3211 | 0.320 |
Why?
|
| Dementia | 6 | 2017 | 2740 | 0.320 |
Why?
|
| Cognition | 4 | 2014 | 7073 | 0.300 |
Why?
|
| Sympathetic Nervous System | 4 | 2007 | 521 | 0.300 |
Why?
|
| Decision Making | 6 | 2010 | 3953 | 0.290 |
Why?
|
| Veterans | 2 | 2021 | 2669 | 0.290 |
Why?
|
| Creatine Kinase | 3 | 2006 | 684 | 0.280 |
Why?
|
| Adrenal Medulla | 2 | 1999 | 56 | 0.260 |
Why?
|
| Sodium Chloride | 1 | 2007 | 584 | 0.240 |
Why?
|
| Leadership | 1 | 2014 | 1397 | 0.240 |
Why?
|
| Temporal Lobe | 3 | 2007 | 1726 | 0.230 |
Why?
|
| Cognition Disorders | 3 | 2007 | 3980 | 0.220 |
Why?
|
| Malignant Hyperthermia | 1 | 2002 | 72 | 0.200 |
Why?
|
| Iron | 2 | 2006 | 1813 | 0.200 |
Why?
|
| Psychiatry | 1 | 2014 | 1716 | 0.190 |
Why?
|
| Psychometrics | 5 | 2007 | 3063 | 0.190 |
Why?
|
| Mental Disorders | 2 | 2021 | 6873 | 0.190 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2008 | 2815 | 0.180 |
Why?
|
| Body Temperature Regulation | 3 | 1999 | 292 | 0.180 |
Why?
|
| Curriculum | 1 | 2014 | 3782 | 0.180 |
Why?
|
| Frontal Lobe | 1 | 2006 | 1426 | 0.170 |
Why?
|
| Residential Treatment | 1 | 2021 | 112 | 0.170 |
Why?
|
| Foster Home Care | 1 | 2021 | 140 | 0.170 |
Why?
|
| Antidiuretic Agents | 1 | 2019 | 21 | 0.160 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2021 | 937 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2014 | 6029 | 0.160 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 1751 | 0.150 |
Why?
|
| Humans | 49 | 2022 | 768171 | 0.150 |
Why?
|
| Schizophrenia, Paranoid | 1 | 2018 | 103 | 0.150 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 3837 | 0.140 |
Why?
|
| Seizures | 2 | 2022 | 2998 | 0.140 |
Why?
|
| Water Intoxication | 1 | 1996 | 10 | 0.140 |
Why?
|
| Male | 33 | 2019 | 364731 | 0.140 |
Why?
|
| Norepinephrine | 1 | 1999 | 898 | 0.130 |
Why?
|
| Comprehension | 3 | 2007 | 638 | 0.130 |
Why?
|
| Hallucinations | 1 | 2018 | 373 | 0.130 |
Why?
|
| Neural Pathways | 1 | 2006 | 3117 | 0.130 |
Why?
|
| Epinephrine | 1 | 1999 | 794 | 0.120 |
Why?
|
| Off-Label Use | 1 | 2017 | 185 | 0.120 |
Why?
|
| Problem Solving | 2 | 2010 | 443 | 0.120 |
Why?
|
| Drug Interactions | 1 | 2019 | 1419 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7454 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2014 | 5953 | 0.110 |
Why?
|
| Factor Analysis, Statistical | 3 | 2005 | 1001 | 0.110 |
Why?
|
| Age of Onset | 2 | 2017 | 3346 | 0.110 |
Why?
|
| Vanilmandelic Acid | 1 | 1992 | 17 | 0.100 |
Why?
|
| Choice Behavior | 3 | 2010 | 848 | 0.100 |
Why?
|
| Enzymes | 1 | 1993 | 254 | 0.100 |
Why?
|
| Health Status | 1 | 2005 | 4091 | 0.100 |
Why?
|
| Catecholamines | 1 | 1992 | 389 | 0.090 |
Why?
|
| Interdisciplinary Studies | 1 | 2011 | 86 | 0.090 |
Why?
|
| Fever | 1 | 2018 | 1614 | 0.090 |
Why?
|
| Psychotic Disorders | 1 | 2006 | 3276 | 0.090 |
Why?
|
| Accreditation | 1 | 2014 | 477 | 0.090 |
Why?
|
| Female | 22 | 2019 | 397187 | 0.090 |
Why?
|
| Arousal | 2 | 1996 | 1180 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2014 | 771 | 0.090 |
Why?
|
| Personality Assessment | 3 | 2005 | 646 | 0.080 |
Why?
|
| Memory | 4 | 2008 | 2207 | 0.080 |
Why?
|
| Adult | 17 | 2018 | 223646 | 0.070 |
Why?
|
| Hyperhidrosis | 1 | 2007 | 34 | 0.070 |
Why?
|
| Models, Psychological | 2 | 1993 | 825 | 0.070 |
Why?
|
| Personal Autonomy | 1 | 2010 | 315 | 0.070 |
Why?
|
| Delphi Technique | 1 | 2011 | 890 | 0.070 |
Why?
|
| Fornix, Brain | 1 | 2007 | 71 | 0.070 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2007 | 111 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2017 | 2649 | 0.070 |
Why?
|
| Middle Aged | 16 | 2019 | 223487 | 0.070 |
Why?
|
| Adrenal Gland Diseases | 1 | 2007 | 141 | 0.070 |
Why?
|
| Severity of Illness Index | 6 | 2007 | 15949 | 0.070 |
Why?
|
| Language Tests | 1 | 2006 | 193 | 0.060 |
Why?
|
| Neurotic Disorders | 1 | 2005 | 77 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2007 | 8759 | 0.060 |
Why?
|
| Dominance, Cerebral | 1 | 2006 | 623 | 0.060 |
Why?
|
| Empirical Research | 1 | 2005 | 119 | 0.060 |
Why?
|
| Haloperidol | 1 | 2006 | 394 | 0.060 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2007 | 269 | 0.060 |
Why?
|
| Ambulatory Care | 3 | 2010 | 2783 | 0.060 |
Why?
|
| Executive Function | 1 | 2013 | 1401 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2014 | 6340 | 0.060 |
Why?
|
| Aged | 14 | 2017 | 171502 | 0.060 |
Why?
|
| Verbal Learning | 1 | 2006 | 465 | 0.060 |
Why?
|
| Telephone | 1 | 2007 | 630 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2006 | 2357 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2018 | 8080 | 0.050 |
Why?
|
| Memory Disorders | 2 | 2007 | 1200 | 0.050 |
Why?
|
| Monoamine Oxidase | 2 | 1995 | 180 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2000 | 1793 | 0.050 |
Why?
|
| Hypothalamus | 2 | 1999 | 1004 | 0.050 |
Why?
|
| Data Collection | 1 | 2011 | 3326 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14729 | 0.050 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2006 | 952 | 0.050 |
Why?
|
| Sex Factors | 3 | 2005 | 10632 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2014 | 8741 | 0.040 |
Why?
|
| Patient Participation | 2 | 2010 | 1447 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 26379 | 0.040 |
Why?
|
| Observer Variation | 1 | 2007 | 2621 | 0.040 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2001 | 147 | 0.040 |
Why?
|
| Attitude | 1 | 2005 | 772 | 0.040 |
Why?
|
| Age Factors | 1 | 2017 | 18415 | 0.040 |
Why?
|
| Intelligence | 1 | 2004 | 926 | 0.040 |
Why?
|
| Adolescent | 6 | 2019 | 89169 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2017 | 4640 | 0.040 |
Why?
|
| Young Adult | 2 | 2017 | 60066 | 0.040 |
Why?
|
| Axons | 1 | 2006 | 1677 | 0.040 |
Why?
|
| Educational Status | 1 | 2006 | 2515 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2002 | 13013 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2005 | 1406 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2005 | 6314 | 0.040 |
Why?
|
| United States | 3 | 2021 | 73039 | 0.030 |
Why?
|
| Thermoreceptors | 1 | 1996 | 27 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2007 | 59626 | 0.030 |
Why?
|
| Depression | 2 | 1995 | 8230 | 0.030 |
Why?
|
| Thermosensing | 1 | 1996 | 56 | 0.030 |
Why?
|
| Brain | 2 | 2001 | 27362 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 657 | 0.030 |
Why?
|
| Attention | 1 | 2006 | 2423 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6229 | 0.030 |
Why?
|
| Functional Laterality | 3 | 2007 | 2264 | 0.030 |
Why?
|
| Body Surface Area | 1 | 1996 | 205 | 0.030 |
Why?
|
| Dehydration | 1 | 1996 | 216 | 0.030 |
Why?
|
| Hospitalization | 2 | 2014 | 10840 | 0.030 |
Why?
|
| Hippocampus | 1 | 2007 | 3783 | 0.030 |
Why?
|
| Models, Biological | 1 | 1990 | 9497 | 0.030 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 1993 | 43 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1836 | 0.030 |
Why?
|
| Metanephrine | 1 | 1992 | 25 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1993 | 412 | 0.030 |
Why?
|
| Blood Platelets | 2 | 1995 | 2479 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 1993 | 414 | 0.020 |
Why?
|
| Affective Symptoms | 1 | 1995 | 418 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 81760 | 0.020 |
Why?
|
| Alcoholism | 2 | 1993 | 1980 | 0.020 |
Why?
|
| Mass Screening | 1 | 2007 | 5458 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1999 | 1776 | 0.020 |
Why?
|
| Child | 1 | 2019 | 80917 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 1993 | 864 | 0.020 |
Why?
|
| Psychoanalytic Theory | 1 | 1990 | 128 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 15453 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 65379 | 0.020 |
Why?
|
| Chronic Disease | 4 | 2007 | 9384 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 74944 | 0.020 |
Why?
|
| Muscles | 1 | 1993 | 1582 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 20225 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 21538 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1999 | 4194 | 0.020 |
Why?
|
| Homeostasis | 1 | 1999 | 3348 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2008 | 504 | 0.020 |
Why?
|
| Thinking | 1 | 2010 | 320 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2007 | 256 | 0.020 |
Why?
|
| Probability | 1 | 1992 | 2479 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 12077 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1992 | 1542 | 0.010 |
Why?
|
| Anisotropy | 1 | 2008 | 1292 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1990 | 1058 | 0.010 |
Why?
|
| Prosopagnosia | 1 | 2005 | 64 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1999 | 4530 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 1434 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 36741 | 0.010 |
Why?
|
| Longevity | 1 | 2010 | 1077 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1992 | 2709 | 0.010 |
Why?
|
| Outpatients | 1 | 2010 | 1600 | 0.010 |
Why?
|
| Social Perception | 1 | 2005 | 434 | 0.010 |
Why?
|
| Mental Recall | 1 | 2007 | 1226 | 0.010 |
Why?
|
| Face | 1 | 2007 | 1031 | 0.010 |
Why?
|
| Comorbidity | 1 | 1995 | 10590 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1892 | 0.010 |
Why?
|
| Visual Perception | 1 | 2008 | 1401 | 0.010 |
Why?
|
| Affect | 1 | 2007 | 1495 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2006 | 22290 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1992 | 8543 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1993 | 4423 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7852 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2005 | 1732 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 169285 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2004 | 6684 | 0.010 |
Why?
|
| Quality of Life | 1 | 2010 | 13490 | 0.000 |
Why?
|
| Reference Values | 1 | 1995 | 4939 | 0.000 |
Why?
|
| Prognosis | 1 | 2006 | 30009 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 39354 | 0.000 |
Why?
|
| Emotions | 1 | 1995 | 2767 | 0.000 |
Why?
|